J. L. Dul

Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.

Anatoly Dritschilo, Chao Huang, Charles M. Rudin et al. · Clinical Cancer Research · 2006 · 88 citations

Medicine, Oncology, Pharmacology +15

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel

Gerald J. Fetterly, Thaddeus H. Grasela, Jeffrey W. Sherman et al. · Clinical Cancer Research · 2008 · 73 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Final results of a phase I study of liposome encapsulated SN-38 (LE-SN38): Safety, pharmacogenomics, pharmacokinetics, and tumor response

Eric H. Kraut, Mayer Fishman, Patricia LoRusso et al. · Journal of Clinical Oncology · 2005 · 31 citations

Medicine, Pharmacokinetics, Pharmacology +17

Final results of a Phase I study of Liposome Entrapped Paclitaxel (LEP-ETU) in patients with advanced cancer

Nevena Damjanov, Mayer Fishman, J. L. Steinberg et al. · Journal of Clinical Oncology · 2005 · 14 citations

Pharmacy, Pharmacokinetics, Pharmacology +16